Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0059 USD -0.00 ( 1.67%)
Last update at 2026-11-20T20:56:00Z
VOLUME
200600
Market Cap
2.10M

Momentum Score

…

Dogecoin Cash, Inc., through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. It also develops Lozenges for relief; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC, as well as intends to offer hi branded men's and women's fashion from suppliers through its www.cbds.com website. In addition, the company holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and cannabis industries. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.07
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Dogecoin Cash, Inc. (OTCQB: DOGP.US) are sparse and its core business and operations are not clearly described in readily available filings. Because detailed strategic and financial information is limited, major long-term growth drivers are not identified and investors may find the company attractive only if it provides a credible plan to generate revenue or clearer disclosure of its strategy.
The most important investment risk is limited transparency and public disclosure, which increases liquidity, governance and execution risk for shareholders.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.74M
Revenue Per Share
0.01
Gross Profit TTM
0.47M
Debt / Equity
-
ROE
-28775.59%
Net Debt
0.58M
ROCE
-39.42%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -10.04M -1.78M -1.32M -1.26M -2.35M
Minority interest 9.47M 0.05M -0.07M 0.05M -0.03M
Net income -0.57M -1.73M -1.39M -1.22M -2.45M
Selling general administrative 1.02M 1.18M 1.48M 2.20M 2.72M
Gross profit 0.47M 0.49M 0.77M 0.96M 1.14M
Reconciled depreciation 0.00M 0.00M 0.15M 0.16M 0.19M
Operating income -0.55M -0.69M -0.86M -1.40M -1.75M
Interest expense 0.09M 0.22M 0.06M 0.03M 0.07M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.09M -0.22M -0.06M -0.03M -0.07M
Total revenue 0.74M 0.80M 1.17M 1.56M 1.84M
Total operating expenses 1.29M 1.50M 2.03M 2.96M 3.59M
Cost of revenue 0.27M 0.31M 0.40M 0.60M 0.70M
Total other income expense net -9.40M -0.87M -0.41M 0.17M -0.54M
Net income from continuing ops -10.04M -1.78M -1.32M -1.26M -2.35M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.23M 1.71M 2.02M 2.57M 2.56M
Intangible assets 0.00M 0.00M 0.01M 0.16M 0.32M
Other current assets - - 0.01M - -
Total liab 2.26M 1.84M 1.26M 0.99M 1.52M
Total stockholder equity -1.87M -1.44M -0.60M 0.29M -0.29M
Capital stock 0.16M 0.15M 0.09M 0.05M 0.03M
Retained earnings -84.39M -83.82M -82.08M -80.69M -79.48M
Good will 1.28M 1.28M 1.78M 1.84M 1.84M
Cash 0.03M 0.03M 0.08M 0.10M 0.19M
Total current liabilities 0.84M 0.72M 0.49M 0.56M 1.52M
Net debt 0.58M 0.50M 0.20M 0.16M 1.02M
Short long term debt 0.61M 0.54M 0.28M 0.26M 1.22M
Total current assets 0.94M 0.35M 0.16M 0.48M 0.40M
Short term investments 0.92M 0.32M 0.07M 0.38M 0.21M
Inventory - - - - 0.00M
Accounts payable 0.19M 0.15M 0.18M 0.25M 0.10M
Non current assets total 1.28M 1.36M 1.86M 2.09M 2.16M
Capital lease obligations - 0.00M 0.01M 0.04M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M 0.01M 0.00M 0.04M
Net borrowings 0.03M 0.06M 0.06M 0.20M 0.04M
Total cash from financing activities 0.03M 0.06M 0.06M 0.20M 0.10M
Net income -0.57M -1.73M -1.39M -1.22M -2.45M
Change in cash -0.01M -0.05M -0.01M -0.10M -0.13M
Begin period cash flow 0.03M 0.08M 0.10M 0.19M 0.32M
End period cash flow 0.03M 0.03M 0.08M 0.10M 0.19M
Total cash from operating activities -0.04M -0.11M -0.06M -0.24M -0.25M
Issuance of capital stock - - - 0.00M 0.01M
Depreciation 0.00M 0.00M 0.15M 0.16M 0.19M
Change to inventory - - - 0.00M 0.03M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.05M 0.28M -0.07M 0.17M 0.10M
Other non cash items 0.41M 0.52M 0.63M 0.86M 1.51M
Free cash flow -0.04M -0.11M -0.06M -0.24M -0.25M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
DOGP
Dogecoin Cash, Inc.
-0.00
1.67%
0.01 - - 2.84 2.13 2.39 -2.10
VEEV
Veeva Systems Inc Class A
-0.05
0.02%
266.22 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-6.60
5.03%
124.50 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
-5.60
9.39%
54.01 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.07
1.31%
5.28 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Dogecoin Cash, Inc.

Dogecoin Cash, Inc., through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. It also develops Lozenges for relief; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC, as well as intends to offer hi branded men's and women's fashion from suppliers through its www.cbds.com website. In addition, the company holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and cannabis industries. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.

355 West Mesquite Blvd, Mesquite, NV, United States, 89027

702 762 3123

4

Name Title Year Born
Mr. David M. Tobias Chairperson, CFO, CEO, President & Secretary 1951
Ms. Catherine J. Carroll Treasurer & Director 1941
Ms. Carolyn Merrill Controller 1967

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…